Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of gender on effective dose of alfentanil for cardiovascular response to double-lumen bronchial intubation
ChiCTR2000035870Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoints: Mean arterial pressure and Heart rate. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
alfentanil
Beyond the preview
Go deeper on ChiCTR2000035870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035870.